Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system
US5082670A · kind A · utility
352Cited by
1References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 15, 1988 |
| Grant date | Jan 21, 1992 |
| Priority date | — |
| Expiry date | Dec 15, 2008 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/948
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.